Source: PR Newswire
  • Cansortium (CSE:TIUM-U) has announced the opening of it’s 19th Fluent medical dispensary in Florida
  • It opened its doors on February 20, and is the first of several to be completed this year
  • The 1,400 sq ft location will serve Panama City and its surrounding areas
  • Cansortium shares are currently trading at C$0.30, with a market cap of C$23.67 million

Cansortium (CSE:TIUM-U), which operates under the brand Fluent, has announced the opening of its 19th medical cannabis dispensary in Florida.

The company is a vertically integrated provider, which stocks its outlets with a range of high-quality medical cannabis flowers, oils and other products.

Its latest Fluent store is the first to reach completion this year, with several more under way.

The 1,400 sq ft site will serve the Panama City area, as well as surrounding regions.

Panama City is home to two US military bases, several large private employers, and three university campuses.

“We continue to expand our Florida dispensary network, enhancing access to premium- quality Fluent cannabis products for medical marijuana patients across the state,” said Consortium CEO, Jose Hidalgo.

Mr. Hidalgo also said that the addition of the store is key to the company’s growth across the Florida panhandle, and solidifies its position in the second-largest and fastest-growing US market.

Each of Fluent’s 19 dispensaries carry products that are cultivated, processed and packaged in it’s Florida-based facilities to meet strict regulatory requirements.

The announcement highlighted the sleek and modern environment of its dispensaries with “a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff…”

Cansortium is now working to expand its footprint in other states, including Michigan, Texas and Pennsylvania, where it has secured licenses and established operations.

Shares in the company are currently trading at C$0.30, with a market cap of C$23.67 million.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.